• Aucun résultat trouvé

Co-infection, super-infection and viral interference in HIV

N/A
N/A
Protected

Academic year: 2021

Partager "Co-infection, super-infection and viral interference in HIV"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: inserm-00868810

https://www.hal.inserm.fr/inserm-00868810

Submitted on 2 Oct 2013

HAL is a multi-disciplinary open access

archive for the deposit and dissemination of

sci-entific research documents, whether they are

pub-lished or not. The documents may come from

teaching and research institutions in France or

abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est

destinée au dépôt et à la diffusion de documents

scientifiques de niveau recherche, publiés ou non,

émanant des établissements d’enseignement et de

recherche français ou étrangers, des laboratoires

publics ou privés.

Co-infection, super-infection and viral interference in

HIV

Azaria Remion, Marc Delord, Sentob Saragosti, Fabrizio Mammano

To cite this version:

Azaria Remion, Marc Delord, Sentob Saragosti, Fabrizio Mammano. Co-infection, super-infection

and viral interference in HIV. Retrovirology, BioMed Central, 2013, 10 (Suppl 1), pp.P72.

�inserm-00868810�

(2)

P O S T E R P R E S E N T A T I O N

Open Access

Co-infection, super-infection and viral

interference in HIV

Azaria Remion

1*

, Marc Delord

2

, Sentob Saragosti

1

, Fabrizio Mammano

1

From Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts

Cambridge, UK. 16-18 September 2013

Background

Viral interference is a phenomenon by which a virus-infected cell displays reduced susceptibility to re-infection. This phenomenon, also called superinfection resistance, is generally due to occupation or down-modulation of cellu-lar receptors. In this respect, the principal mechanism of HIV superinfection resistance is down-modulation of the CD4 receptor from the cell surface mediated by Env, Vpu and Nef. Recent data, however, strongly suggest that HIV superinfection resistance also involves CD4-independent mechanisms that remain to be fully understood. Our aim was to explore the dynamics and mechanisms of CD4-independent viral interference in HIV.

Material and methods

To quantify the infection by the first and the super-infect-ing virus, we used two isogenic HIV proviral clones, differ-ing only in the expression of a marker protein (GFP and HSA). To analyze the dynamics of viral interference, the superinfecting virus was added at different times after the initial virus (0, 3, 6, 12, 18 and 24h). We prevented virus spread in culture by using single cycle virus infection. The number of cells expressing none, one, or both reporter proteins were measured by FACS analysis, and used to determine whether double infection occurred at frequen-cies expected for independent infection events.

Results

In the case of co-infection (two viruses added at the same time), the frequency of double infected cells was signifi-cantly higher than it would be expected if the two infec-tion events were independent. This result is consistent with previous literature [1].

By delaying the infection of the second virus (super-infection) and comparing the frequency of double infected

cells to those observed for co-infection, we show evidence of viral interference starting 6h post-initial infection, which gained statistical significance when the second infection was performed 18h and 24h after the first one. Using a virus pseudotyped by the amphotropic-MLV Env for the second infection, we measured a similar level of interference up to 18h post-initial infection. This result strongly suggests that, for these early time points, virus interference is a CD4-independent phenomenon.

Conclusions

Our experimental system allowed us to explore the effi-ciency of coinfection and the kinetics of viral interference in HIV. We confirmed that co-infection leads to a higher frequency of double infected cells than would be expected for independent infection events. In the setting of super-infection, only a few hours are required for the induction of measurable viral interference. This rapid phenomenon is largely independent of CD4-expression. Our experimen-tal system will allow the exploration of the viral genes and the cellular mechanisms responsible for the early establish-ment of HIV interference.

Acknowledgments

This work was supported in part by Conseil Régional Martinique.

Authors’ details

1

INSERM U941, Université Paris Diderot, Paris, France.2Hôpital Saint-Louis, Paris, France.

Published: 19 September 2013

Reference

1. Dang, et al: Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. Proc Natl Acad Sci U S A 2004, 101:632-637.

doi:10.1186/1742-4690-10-S1-P72

Cite this article as: Remion et al.: Co-infection, super-infection and viral interference in HIV. Retrovirology 2013 10(Suppl 1):P72.

1INSERM U941, Université Paris Diderot, Paris, France

Full list of author information is available at the end of the article Remion et al. Retrovirology 2013, 10(Suppl 1):P72

http://www.retrovirology.com/content/10/S1/P72

© 2013 Remion et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Références

Documents relatifs

Ainsi, comparée à celle observée dans des souris infectées uniquement par l’EBV, pour lesquelles la majorité des cellules infectées arborent une latence de type III, la

The cell line was cured of the virus, and both BVDV-infected and BVDV-free Bomac cells were tested for mycoplas- mal uptake, growth in co-culture, viability, cytotoxic- ity

Fungus- stimulated MDDCs significantly enhanced the capacity to mediate HIV-luc/JRFL or HIV-luc/NL4-3 trans infection of HutCCR5 cells, there was a 4.8- to 6.5-fold increase

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of

All people at substantial risk of HIV infection who could be eligible for PrEP should be offered HIV testing services. Prior to starting or restarting PrEP, it is critical to rule

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of

Following the WHO recommendation in September 2015 that “oral pre-exposure prophylaxis (PrEP) should be offered as an additional prevention choice for people at substantial risk of